How Nutritional Deficiencies Impact Health Economics in the Hospital Setting

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Shelby Yaceczko, MS, RDN-AP, CNSC

The burden of malnutrition across the globe is very high, with hospitals and care teams being directly impacted. Here with Dr. Mary Katherine Cheeley to share what we need to know about the relationship between nutritional deficiencies and health economics in the hospital is Ms. Shelby Yaceczko, an Assistant Clinical Professor in the Department of Nutrition at the University of the Pacific in Sacramento, California.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Kathryn Gallagher, MS, RN, BSN
Guest: Kate Newcomb-DeSanto, MSN, RN, MSW

What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Chris H. Cooper

Can new mask technology made with innovative materials better protect us from the coronavirus? Dr. Charles Turck speaks with Chris Cooper, Chief Science Officer and CEO of Airlock389, on improving mask technology after the supply shortage of masks during COVID-19.

Host: Linda Bernstein, Pharm.D.

The U.S. Food and Drug Administration announced its approval of Ebanga (Ansuvimab-zykl) for the treatment of the ebola virus infection in adults and children. To learn more about the second ebolavirus treatment to receive approval, Dr. Linda Bernstein walks us through this new drug.

Published December 29, 2020

Host: Linda Bernstein, Pharm.D.

As a growing number of pharmaceutical companies refuse to provide discounts to 340B hospitals for drugs dispensed at community-based pharmacies, a federal lawsuit is challenging the U.S. Department of Health and Human Services in order to fight for patient communities harmed by this refusal. On this episode of The Drug Report, Dr. Linda Bernstein dives into this lawsuit.

Host: Linda Bernstein, Pharm.D.

A sedative commonly used in anesthesia, dexmedetomidine hydrochloride has been the subject of many news reports over the past few months. But most recently, the FDA announced approval for Aurobindo Pharma’s dexmedetomidine hydrochloride in 0.9% sodium chloride injection. In this episode of The Drug Report, Dr. Linda Bernstein reviews recent approvals of dexmedetomidine hydrochloride on initially intubated and mechanically ventilated patients.

Published December 17, 2020

Host: Linda Bernstein, Pharm.D.

Asthma remains a significant global health problem, and more than 25 million Americans suffer from it. How have the National Asthma Education and Prevention Program’s guidelines changed to help manage this chronic condition? In this episode of The Drug Report, Dr. Linda Bernstein reviews new guidelines on the management of asthma in adolescents and adults.

Published December 10, 2020

Host: Linda Bernstein, Pharm.D.

To prevent the flu from spreading concurrently with COVID-19, The U.S. Food and Drug Administration has expanded the approved indication for baloxavir marboxil to include post-exposure prevention of influenza. On this episode of The Drug Report, Dr. Linda Bernstein dives into this oral anti-influenza drug.

Published December 2, 2020

Host: Linda Bernstein, Pharm.D.

Pfizer and BioNTech recently announced that their mRNA vaccine for the COVID-19 virus was 90 percent effective, and the companies plan to apply for Emergency Use Authorization. This episode of The Drug Report dives into this vaccine’s Phase 3 clinical trial and explores developments made by other companies in the search for a COVID-19 vaccine.

Published November 30, 2020